Single-cell transcriptomics of neuroblastoma identifies chemoresistance-associated genes and pathways
High-Risk neuroblastoma (NB) survival rate is still <50%, despite treatments being more and more aggressive. The biggest hurdle liable to cancer therapy failure is the drug resistance by tumor cells that is likely due to the intra-tumor heterogeneity (ITH). To investigate the link between ITH and...
Main Authors: | Marianna Avitabile, Ferdinando Bonfiglio, Vincenzo Aievola, Sueva Cantalupo, Teresa Maiorino, Vito Alessandro Lasorsa, Cinzia Domenicotti, Barbara Marengo, Heger Zbyněk, Adam Vojtěch, Achille Iolascon, Mario Capasso |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Computational and Structural Biotechnology Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2001037022003658 |
Similar Items
-
Noncoding Regulatory Mutations as a Driving Event for the Oncogenic Core Regulatory Circuitries of Neuroblastoma
by: Vincenzo Aievola, et al.
Published: (2024-03-01) -
CFDP1 is a neuroblastoma susceptibility gene that regulates transcription factors of the noradrenergic cell identity
by: Daniela Formicola, et al.
Published: (2023-01-01) -
FGFR1 is a potential therapeutic target in neuroblastoma
by: Flora Cimmino, et al.
Published: (2022-04-01) -
A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma
by: Flora Cimmino, et al.
Published: (2020-12-01) -
Post-GWAS Functional Analysis of the 11p11.2 Risk Locus Identifies <i>HSD17B12</i> as a Neuroblastoma Susceptibility Gene Involved in Lipid Metabolism
by: Teresa Maiorino, et al.
Published: (2024-03-01)